Matson Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.07 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 3.18%
- Profit Growth -23.69%
- Ebitda 35.24%
- Net Worth 43.49%
- Total Assets -0.81%
About Matson Pharma
Matson Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 2016 (Eight years and six months 5 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.07 M.
The company currently has active open charges totaling ₹5.00 M.
Manish Singh, Tripurari Singh, and Pankaj Jha serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2016PTC032161
-
Company No.
032161
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jul 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Matson Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Singh
|
Director | 29-Jul-2016 | Current |
|
Tripurari Singh
|
Director | 29-Jul-2016 | Current |
|
Pankaj Jha
|
Director | 17-Aug-2016 | Current |
Financial Performance of Matson Pharma.
Matson Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.18% increase. The company also saw a substantial fall in profitability, with a 23.69% decrease in profit. The company's net worth Soared by an impressive increase of 43.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Matson Pharma?
In 2019, Matson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2019 | State Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Matson Pharma?
Matson Pharma has a workforce of 29 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Matson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Matson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.